MXRA8-dependent chikungunya virus infection in PDGFRα+ mesenchymal cells increases vascular permeability and facilitates hematogenous spread
This study demonstrates that Chikungunya virus infection of PDGFRα+ mesenchymal cells via the MXRA8 receptor enhances endothelial permeability through VEGF signaling, thereby driving vascular leakage and facilitating hematogenous viral spread.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When a mosquito bites a person, it can inject tiny viruses that travel through the blood to cause severe pain and swelling in the joints. This is the hallmark of diseases like chikungunya, where the body's reaction leaves limbs puffy and stiff for weeks or even years. While scientists have long known that these viruses target specific types of cells in our muscles and skin, the exact mechanism behind the dramatic swelling has remained a mystery. It was unclear whether the virus simply multiplied in one spot to cause the problem, or if it actively disrupted the body's plumbing system to leak fluid into the tissues. Understanding this process is crucial because the swelling is not just a symptom; it is the gateway that allows the virus to escape the local area and spread throughout the body, making the infection much harder to control.
A team of researchers at Washington University School of Medicine set out to solve this puzzle by looking closely at how the chikungunya virus enters cells and moves through the body. They focused on a specific protein on the surface of cells called MXRA8, which acts like a keyhole that the virus uses to unlock and enter. Previous studies showed that mice without this keyhole did not develop foot swelling when infected, but the virus levels in their feet were not significantly lower than in normal mice. This suggested that the swelling was not caused by the sheer amount of virus present, but by something else the virus triggered once it got inside. To find out what that something was, the researchers used a special genetic technique to remove the MXRA8 protein only from specific types of cells in mice, rather than removing it from the entire animal. This allowed them to pinpoint exactly which cells were responsible for the swelling and the spread of the virus.
The researchers discovered that the virus needs to infect a specific group of cells called fibroblast progenitors, which are found in the connective tissue of the foot and rely on the MXRA8 protein to let the virus in. When these cells were infected, they did not just sit there; they began to send out chemical signals that acted on the nearby blood vessels. Specifically, the infected cells produced a substance called VEGF-A, which is known to make blood vessel walls more leaky. In normal mice, this leakage caused fluid to pour out of the blood vessels and into the surrounding tissue, creating the characteristic swelling. However, in mice where the researchers had removed the MXRA8 protein from these specific connective tissue cells, the virus could not infect them, the chemical signal was never sent, and the blood vessels remained tight and sealed. As a result, these mice did not swell up, even though the virus was still present in their feet.
This finding revealed a two-step process that the virus uses to spread. First, it infects the connective tissue cells using the MXRA8 keyhole. Second, these infected cells convince the nearby blood vessels to open their gates, allowing fluid to leak out and cause swelling. The researchers found that this opening of the gates was essential for the virus to escape the foot and enter the bloodstream to travel to other parts of the body. They tested this by injecting a harmless, non-replicating virus particle into the feet of infected mice. In mice with normal connective tissue cells, these particles quickly moved from the foot into the blood. But in mice lacking the MXRA8 protein in those specific cells, the particles stayed trapped in the foot and could not get into the circulation. This proved that the swelling and the leaky blood vessels were not just side effects of the disease, but the very mechanism the virus used to spread itself.
The study also clarified why the virus could infect some cells but not others. The researchers found that while the connective tissue cells needed the MXRA8 protein to let the virus in, the cells that line the blood vessels did not. Instead, the blood vessel cells were naturally resistant to the virus because they had strong internal defenses. However, when the connective tissue cells were infected and started sending out their chemical signals, they weakened these defenses in the blood vessel cells, making them easier to infect. This interaction between the two cell types created a perfect storm: the connective tissue cells got infected, signaled the blood vessels to become leaky, and allowed the virus to slip into the bloodstream. Without the initial infection of the connective tissue cells, this chain reaction never started.
By blocking the chemical signal that caused the blood vessels to leak, the researchers were able to stop the swelling and prevent the virus from spreading to the rest of the body, even though the virus was still present in the foot. This suggests that the swelling is a direct result of the body's blood vessels becoming too permeable, rather than just a buildup of virus particles. The work provides a clear picture of how a virus can hijack the body's own repair mechanisms to facilitate its own spread. It shows that the dramatic swelling seen in chikungunya is not just a passive reaction to infection, but an active process driven by the virus manipulating the cells around it to create a path for itself. This new understanding could help scientists develop treatments that stop the virus from spreading by keeping the blood vessels sealed, rather than just trying to kill the virus itself.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.